Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com
Company Details
- Employees
- 478
- Founded
- -
- Address
- Rue Saint-Georges 5, Liège,belgium 4000,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mithra.com
- HQ
- Liège, Belgium
Mithra Questions
Mithra's website is mithra.com
Mithra's LinkedIn profile is https://be.linkedin.com/company/mithra-pharmaceutical
Mithra has
478 employees.
View email and phone details for 478
employees at Mithra.
Mithra's industry is
Biotechnology Research
Mithra's top competitors are
Eyed Pharma,
Trasis,
Kiomed Pharma,
Exothera,
Kitozyme,
Estetra,
Zentech S.a., Belgium,
Imcyse Sa,
Eurogentec,
Exo Biologics.
Mithra's categories are Biotechnology Research
Mithra's founding year is 1999
